Advanced Search
To read this article in full, please review your options for gaining access at the bottom of the page.

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

Figures

Fig. 1

Summary of neurotransmitter changes associated with AWSs. AWS, alcohol withdrawal syndrome; AWSz, alcohol withdrawal seizures; CRF, corticotropin-releasing factor; DA, dopamine; DT, delirium tremens; GABA, gamma-aminobutyric acid; GLU, glutamate; Mg, magnesium; NA, noradrenaline or norepinephrine; NMDA, N-methyl-D-aspartate receptor.

Fig. 2

Timing of alcohol withdrawal syndromes (AWS).

Fig. 3

Benzodiazepine-sparing alcohol withdrawal prophylaxis and treatment protocol. AWSS, Alcohol Withdrawal Syndrome Scale; BAC, blood alcohol concentration; BZDP, benzodiazepine; CIWA-Ar, Clinical Institute Withdrawal Assessment for Alcohol; PAWSS, Prediction of Alcohol Withdrawal Severity Scale.

Fig. 4

PAWSS.

First page of article

Benzodiazepine (BZDP) agents are the standard for the prophylaxis and treatment of all phases of alcohol withdrawal syndrome. However, BZDPs have their drawbacks: cognitive impairment, significant neurologic and medical side effects. There are data suggesting that the alcohol recidivism rate and abuse potential is higher for BZDPs treated patients, compared to alternatives. Clinical and research data demonstrate the efficacy and safety of various pharmacologic alternatives to benzodiazepines for the prevention and management of AWS. This article examines the available published evidence regarding the use of non-BZDP agents compared with conventional treatment modalities. The author’s BZDP-sparing protocol is highlighted.

To access this article, please choose from the options below

Purchase access to this article

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

Recommended Articles

 

Advertisement